- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
3-(1-(3-(5-bromopyrimidin-2-yl) benzyl)-6-oxo-1,6-dihydropyridazin-3-yl) benzonitrile
Product Name:3-(1-(3-(5-bromopyrimidin-2-yl) benzyl)-6-oxo-1,6-dihydropyridazin-3-yl) benzonitrile
Formulae hypotheticae: C22H14BrN5O
Molecular pondus:444.28
CAS Subcriptio Number:1103506-77-9
N-Boc-4-piperidinemethanol
Product Name:N-Boc-4-piperidinemethanol
Formulae hypotheticae: C11H21NO3
Molecular Weight:215.29
CAS Subcriptio Number:123855-51-6
(3-(5-broMopyriMidin-2-yl)phenyl)Methanol
Product Name:(3-(5-broMopyriMidin-2-yl)phenyl)Methanol
Formulae hypotheticae: C11H9BrN2O
Molecular pondus:265.11
CAS Subcriptio Number:1092568-90-5
5-broMo-2-(3-(chloroMethyl) phenyl) pyriMidine
Product Name:5-broMo-2-(3-(chloroMethyl)phenyl)pyriMidine
Formulae hypotheticae: C11H8BrClN2
Molecular Weight:283.55
CAS Registry Number: 1100598-50-2
3-(6-Oxo-1,6-dihydro-3-pyridazinyl) benzonitrile
Product Name:3-(6-Oxo-1,6-dihydro-3-pyridazinyl) benzonitrile
Formulae hypotheticae: C11H7N3O
Molecular pondus:197.19
CAS Registry Number: 52240-08-1
N-acetyl-10-deacetyl-N-debenzoylpaclitaxel
Product Name:N-acetyl-10-deacetyl-N-debenzoylpaclitaxel
Formulae hypotheticae: C40H47NO13
Pondus hypotheticum: 749.81
CAS Registry Number: 1144034-42-3
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
